Explore tweets tagged as #TheViewOnGU
From Berlin to your ears, Dr. @LalaniMD and Dr. @WallisCJD bring the most important highlights from #ESMO25 straight to you! Our @myESMO Series releases Oct 28, featuring three episodes packed with the latest breakthroughs in #GUOncology: https://t.co/kSQYsytayu
0
2
4
Fantastic recording for @theviewongu with my buddy @lalaniMD here in Berlin for @myESMO #esmo25 Stay tuned for updates in #bladdercancer, #proststecancer, and #kidneycancer dropping soon
0
3
7
đReporting live from Day 1 at #ESMO25! Hallo aus Berlin đ©đȘ The View on GU team is on the ground in Berlin, ready to dive into the latest in #GUOncology.
1
1
6
Dr. @LalaniMD and Dr. @WallisCJD are deep in planning mode for another exciting season of #TheViewOnGU! Expect new topics, expert guests and the latest key clinical data đ Donât miss a thing, subscribe now: https://t.co/kSQYsytayu
0
1
5
#ESMO25 is just a few days away! In our newest episode, Dr. @LalaniMD and Dr. @WallisCJD were thrilled to welcome Dr. @MontyPal for an inside look at what to expect from this yearâs @myESMO Congress. Episode 29 is now live - watch or listen now: https://t.co/kSQYsytayu
0
2
7
Do you work in medicine and often wonder how a drug gets approved in Canada? đ In Episode 28, Sudha Kutty (@CDA_AMC) sits down with Dr. @LalaniMD and Dr. WallisCJD to review the journey from Health Canada filing to recommendations. Watch or listen now: https://t.co/kSQYsytIo2
0
0
1
đšHavenât caught Episode 28 of The View on GU yet? Sudha Kutty of @CDA_AMC walks Dr. @LalaniMD and Dr. @WallisCJD through Canadaâs drug review process, from file acceptance to draft recommendations in ~166 days. Watch or listen: https://t.co/kSQYsytIo2
0
1
2
SFO - letâs go! Stay tuned to @theviewongu for all the highlights from #ascoGU25
We'll be filming live at 2025 @ASCO Genitourinary Cancer Symposium, which starts tomorrow! @lalaniMD and @WallisCJD will weigh-in with their reactions, considerations, and key learnings from the sessions and presentations in an exciting 3-episode series. Stay tuned! #GU25
0
1
16
Episode 28 is live! Dr. @lalaniMD and Dr. @WallisCJD chat with Sudha Kutty (@CDA_AMC) about the latest drug approval and reimbursement insights for HCPs across every therapeutic area. Donât miss it! Listen now: https://t.co/kSQYsytayu
0
1
4
Whether you were an early adopter or a skeptic to date, impactful data from @DrChoueiri on KN-564 at #gu24: OS benefit of adjuvant pembro in ccRCC Check out thoughts from @lalaniMD and I on upcoming @theviewongu episode.
1
1
14
Great recording with my buddy @lalaniMD. Stay tuned for our next episode of @theviewongu coming out soon and check out past episodes here: https://t.co/K36XULGyRp
0
2
20
At #jcc24, @tompowles1 argues for adjuvant pembro in resected RCC. If KN564 data arenât sufficient to recommend this approach, is the bar reasonable? Clearly not right for all patients but warrants conversation @CanUrolAssoc @lalaniMD @theviewongu
0
2
11
0
3
13
With #ProstateCancerAwarenessMonth only days away, nowâs the perfect time to catch our latest episode. Join Drs. Kinnaird, @LalaniMD and @WallisCJD as they discuss the future of #ProstateCancer imaging: https://t.co/kSQYsytayu
0
1
2
Are you en route to Berlin, Germany for #ESMO25? âïž As you travel, watch or listen to the most recent episode of #TheViewonGU! Episode 29 welcomes Dr. @MontyPal for a discussion about what to expect at this yearâs @myESMO Congress. Watch or listen now: https://t.co/kSQYsytayu
0
0
1
Have you caught Episode 27 yet? đ Donât miss Dr. Adam Kinnaird breaking down the latest in #ProstateCancer imaging, from biopsy strategies and antibiotic use to how to handle conflicting results. Watch or listen now wherever you get your podcasts: https://t.co/kSQYsytayu
0
0
1
Catch up on Episode 28 as Dr. @LalaniMD & @WallisCJD discuss with Sudha Kutty how @CDA_AMC is driving innovation across its initiatives: https://t.co/kSQYsytIo2
0
1
2
Better counseling may reduce treatment-related regret in the management of localized prostate cancer. @WallisCJD summarizes 10-year data on patient reported outcomes following surgery or radiotherapy. #PMCC24 @CanUrolAssoc @TheViewOnGU
0
1
9